Two-year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure - The New England Journal of Medicine - 2018

Brief Summary:

In patients with advanced heart failure refractory to medical management referred for durable left ventricular assist device (LVAD) placement, a magnetically levitated centrifugal-flow device was associated with 19.3% absolute reduction in reoperation for device malfunction or disabling stroke at 2 years. This was driven primarily by a 15.4% absolute reduction in the need for reoperation for device malfunction, although there was also a 9.1% absolute reduction in overall stroke (not disabling stroke).